Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia

Journal of Urology

Volumn 174, Issue 4 I, 2005, Pages 1327-1333

  McVary, Kevin T ^a   Rademaker, Alfred ^a   Lloyd, Granville L ^a   Gann, Peter ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autonomic nervous system; Prostate; Prostatic hyperplasia; Questionnaires; Urodynamics

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; HEALTH SURVEY; HEART RATE; HUMAN; MALE; MULTIPLE REGRESSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SCORING SYSTEM; SYMPTOMATOLOGY; TILT TABLE TEST; URETHRA DISEASE; URODYNAMICS;

EID: 19744377382     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000173072.73702.64     Document Type: Article

References (19)

1. Grayhack, J. T., McVary, K. T. and Kozlowski, J. M.: Benign prostatic hyperplasia. In: Adult and Pediatric Urology, 4th ed. Edited by J. J. Gillenwater, J. T. Grayhack, S. S. Howards and M. W. Mitchell. Phiadelphia: Lippincott Williams and Wilkins Publishers, vol. 2, pp. 1401-1470, 2001
2. McVary, K. T., Razzaq, A., Lee, C., Venegas, M. F., Rademaker, A. and McKenna, K. E.: Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod, 51: 99, 1994
3. Golomb, E., Rosenzweig, N., Eilam, R. and Abramovici, A.: Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl, 21: 58, 2000
4. Glynn, R. J., Campion, E. W., Bouchard, G. R. and Sibert, J. E.: The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol, 121: 78, 1985
5. Hammarsten, J. and Hogstedt, B.: Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press, 8: 29, 1999
6. Steers, W. D., Clemow, D. B., Persson, K., Sherer, T. B., Andersson, K. E. and Tuttle, J. B.: The spontaneously hypertensive rat: insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. Exp Physiol, 84: 137, 1999
7. Bautista, O. M., Kusek, J. W., Nyberg, L. M., McConnell, J. D., Bain, R. P., Miller, G. et al: Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial. Control Clin Trials, 24: 224, 2003
8. McConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L., Jr., Dixon, C. M., Kusek, J. W. et al: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med, 349: 2387, 2003
9. Ware, J. E., Jr.: A MOS Short-Form Health Survey (SF-36). Boston: The Health Institute, New England Medical Center, 1988
10. Jacobs, D. R., Hahn, L. P., Haskell, W. L., Pirie, P. and Sidney, S.: Validity and reliability of short physical activity history: CARDIA and the Minnesota Heart Health Program. J Cardiopulm Rehabil, 9: 448, 1989
11. Meigs, J. B., Mohr, B., Barry, M. J., Collins, M. M. and McKinlay, J. B.: Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol, 54: 935, 2001
12. Grubb, B. P. and Kosinski, D. J.: Syncope resulting from autonomic insufficiency syndromes associated with orthostatic intolerance. Med Clin North Am, 85: 457, 2001
13. Bonanni Rey, R. A., Guinjoan, S. M. and and Cardinali, D. P.: Some neurovegetative correlates of Minnesota Multiphasic Personality Inventory (MMPI). Acta Physiol Pharmacol Ther Latinoam, 42: 147, 1992
14. Walters, M. D., Taylor, S. and Schoenfeld, L. S.: Psychosexual study of women with detrusor instability. Obstet Gynecol, 75: 22, 1990
15. Camilleri, M. and Ford, M. J.: Functional gastrointestinal disease and the autonomie nervous system: a way ahead? Gastroenterology, 106: 1114, 1994
16. Tong, Y. C., Hung, Y. C., Lin, S. N. and Cheng, J. T.: The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive rat. J Auton Nerv Syst, 56: 215, 1996
17. Juarranz, M. G., Bodega, G., Prieto, J. C. and Guijarro, L. G.: Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation. Prostate, 47: 285, 2001
18. Smith, E. R., Miller, T. B., Wilson, M. M. and Appel, M. C.: Effects of vasoactive intestinal peptide on canine prostatic contraction and secretion. Am J Physiol, 247: R701, 1984
19. Roehrborn, C. G., McConnell, J. D., Kusek, J. W., Nyberg, L. M., Slawin, K. M., McVary, K. T. et al: Impact of baseline PSA and TRUS volume on longitudinal changes in IPSS and maximum flowrate in MTOPS. J Urol, suppl., 171: 241, abstract 911, 2004